Mylan launches Tecfidera generic amid Biogen battle
20-08-2020
English appeals court refuses Neurim injunction for insomnia drug
26-06-2020
Mylan scores multiple sclerosis patent win over Biogen
23-06-2020
ricochet64 / Shutterstock.com
The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Mylan, Federal Court of Australia, Sun Pharma, patent, infringement, generics, cholesterol, fenofibrate
